Revolution Medicines advisor Stephen Michael Kelsey reports sale of $4.56 million in shares
RVMD•Senior advisor to the CEO Stephen Michael Kelsey sold 27,160 Revolution Medicines common shares on Nov. 16, 2026, at prices ranging from $166.7506 to $171.65 per share.




